$APVO Aptevo Therapeutics Inc. Insider Trading
Get free email notifications about insider trading in Aptevo Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aptevo Therapeutics Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aptevo Therapeutics Inc. for free.
CIK Number: 0001671584
IRS Number: 811567056
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: APVO
Company Address: 2401 4TH AVE. SUITE 1050 SEATTLE 98121
Market Capitalization: $39.89M
Prev close: $1.95
Average Daily Volume: 236,153
Days Low: $1.90
Year Low: $1.69
Year High: $8.29
Aptevo Therapeutics Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 0.00 | 893 | 0 | 893 | |
Jun 02 2021 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 26.15 | 2,678 | 70,030 | 2,678 | |
Jun 02 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 0.00 | 893 | 0 | 893 | |
Jun 02 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 26.15 | 2,678 | 70,030 | 2,678 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 0.00 | 14,375 | 0 | 14,375 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | White Marvin L | President and CEO | Option Exercise | A | 33.50 | 43,125 | 1,444,688 | 43,125 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Niederhuber John | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 0.00 | 5,500 | 0 | 5,500 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Lamothe Jeffrey G. | SVP and CFO | Option Exercise | A | 33.50 | 16,500 | 552,750 | 16,500 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Kunz Barbara Lopez | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Harsanyi Zsolt | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 0.00 | 5,500 | 0 | 5,500 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Gross Jane A | SVP & Chief Scienti ... | Option Exercise | A | 33.50 | 16,500 | 552,750 | 16,500 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | Grant Grady III | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 | |
Feb 17 2021 | APVO | Aptevo Therapeutic ... | El-Hibri Fuad | Director | Option Exercise | A | 9.18 | 3,571 | 32,782 | 3,571 |